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Abstract
Increasing evidence suggests that parturition is an inflammatory process. In this brief overview,
inflammatory events occurring in association with parturition, and the mechanism by which they
may contribute to labour and delivery will be discussed. Mention will be made of how this
information may be of use in regulating the timing and the onset of parturition.
Background
Preterm birth is the single biggest cause of perinatal mor-
tality and morbidity. Preterm birth rates are rising in all
developed countries. In Scotland, there has been a pro-
gressive rise in preterm birth rates from 5.8% in 1980 to
7.6% in 2005 [1]. Work from our own and other groups
increasingly suggests that parturition is an inflammatory
process, and we anticipate that further understanding of
these events will contribute to interventions to prevent
preterm birth. Inflammation can either be an acute or a
chronic event. The acute event is characterised by its short
duration (minutes – days), blood vessel dilation and leak-
iness, exudation of fluid and plasma proteins and emigra-
tion of leukocytes.
Myometrial events
Our interest in the possible role of inflammation in pre-
term labour was sparked in 1999. We initially performed
myometrial biopsies from a group of women during Cae-
sarean section in labour (n = 18) being careful to exclude
women with clinical signs of infection, those who had
received oxytocic or prostaglandin drugs and those who
had a cervical dilation of less than 4 cm or greater than 8
cm. We also obtained myometrial biopsies from a cohort
of women who underwent Caesarean section prior to the
onset of labour. Histology slides were prepared and
stained with relevant antibodies: neutrophil elastase or
CD15 to identify neutrophils, CD68 to identify macro-
phages, CD3 for T cells and CD20 for B cells. Slides were
then examined, and the number of cells counted in five
high powered fields by two observers working independ-
ently and who were unaware of the clinical details of the
subject. We demonstrated that there was a massive influx
of inflammatory cells (neutrophils and macrophages)
into both the lower and the upper segment of myo-
metrium in association with physiological labour [2]. The
magnitude of leukocyte invasion was greatest in the lower
segment, with an increase in T cell density only occurring
in the lower segment, and no increase in B cell density in
either location.
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Later, by performing Northern analysis on biopsies of
myometrium taken from each of labouring and non
labouring women, we established that this leukocytic
influx was paralleled by up-regulation of pro-inflamma-
tory cytokine mRNA expression, specifically IL-1β, IL-6
and IL-8 [3]. In subsequent studies where we stained back
to back sections with antibodies against the cytokines IL-
1β, IL-6 and IL-8 and with leukocyte cell surface markers
we determined that protein expression of these pro-
inflammatory cytokines was largely (although not exclu-
sively) confined to invading leukocytes [4]. Lastly, we
examined ICAM-1, an endothelial adhesion molecule
which facilitates adhesion, arrest and transmigration of
leukocytes and demonstrated that myometrium expresses
greater amounts of ICAM-1 during labour, compared to
immediately prior to parturition [5]. Collectively this
body of work in conjunction with studies by other groups
suggests a co-ordinated mechanism by which leukocytes
can traffic into the myometrium, and can release pro-
inflammatory cytokines to amplify or initiate the process
of parturition.
Our data do not prove that pro-inflammatory cytokines
are integral to the pathophysiology of labour. However,
there is good evidence that pro-inflammatory cytokines
will contribute to stimulation of uterine contractions. For
example, in cultured human myometrial cells, Tribe et al
showed that IL-1β induces both basal and store operated
calcium entry in myometrial smooth muscle cells, thus
directly increasing their contractile ability/activity [6].
Oger and colleagues demonstrated that IL-1β, stimulates
phosphodiesterase (PDE) activity [7]. Since PDE breaks
down cAMP, which maintains myometrial quiescence, IL-
1β would thus stimulate uterine contractions. Others have
shown that IL-1βB stimulates production of both PGF2α
production [8] and PGF2α receptors, which will further
contribute to myometrial contractions. Further work from
other groups also established that pro-inflammatory
cytokines may contribute to the myometrial remodelling
which occurs with labour [9]. These data all need to be
interpreted with caution, because the experiments were
performed in myometrial cells rather than whole tissue or
in vivo, but if they can be replicated in more physiological
conditions it seems likely that the influx of leukocytes
(which is the hallmark of inflammation) can contribute
directly to the pathophysiology of parturition.
A more recent study in our department using DNA micro-
arrays to identify differences in the transcriptional profiles
in labouring and non labouring myometrium, demon-
strated that out of the top 5 upregulated genes, two are pri-
marily related to inflammation (interleukin 8 and
chemokine [C-X-C motif] ligand 5), and two are related to
tissue remodelling (matrix metallopeptidases 1 and 10
respectively) (Bollopragada et al, unpublished data). We
are currently analysing this data in more detail, however,
consistent with our previous work it indicates the impor-
tance of inflammation in the process of parturition.
Cervical events
The description of cervical ripening as an inflammatory
reaction is not new, being made by Liggins in the early
1980s. Again, we have shown that labour is associated
with a massive influx of leukocytes into the cervix [3], and
that pro-inflammatory cytokines and cell adhesion mole-
cules are co-incidentally expressed. Additionally, nitric
oxide, made from L-arginine by one of three nitric oxide
synthase enzymes, seems to have an important role in cer-
vical ripening. Each of the three nitric oxide synthase
enzymes is produced in the cervix, and we and others have
shown increased expression of inducible NOS in associa-
tion with cervical ripening [10,11]. Nitric oxide release
and the concurrent up-regulation of inducible nitric oxide
synthase are common events in inflammation, and sug-
gest that these pro-inflammatory agents may be useful in
the initiation of parturition. Consequently we have been
investigating clinically the use of nitric oxide donors as
cervical ripening agents. Nitric oxide donors have a signif-
icant advantage over prostaglandins, the current agent of
choice for cervical ripening, because nitric oxide donors
relax the uterus. Uterine contraction before the cervix is
ripe is ineffective in progressing labour, and merely
reduces blood flow to the baby. In 5 – 10% women this is
sufficient to cause fetal distress (which may require treat-
ment by Caesarean section), and consequently, cervical
ripening is carried out as an inpatient procedure.
Although less effective than prostaglandins in the doses
currently investigated, nitric oxide donors appear to be
safe and well tolerated for cervical ripening, and tend to
be preferred by women [12-14]. They may therefore be
suitable for use on an outpatient basis, and their efficacy
in this regard is currently under investigation [15].
Fetal membranes
In contrast to data from the cervix and myometrium, we
have been unable to show an increase in leukocyte cell
density in fetal membranes, comparing labouring with
non labouring tissue [16]. There is however a significant
upregulation of IL-1β, and IL-6 in labour. A genomic
study from another group has confirmed that fetal mem-
branes in labour do indeed have an acute inflammatory
signature [17]. The source of this inflammatory activity is
unknown: whether production of cytokines from resident
inflammatory cells increases, or whether other cells con-
tribute to the increase in IL-1β and IL-6 production. Fur-
ther studies are required to investigate this issue, however,
comparative analysis of this membrane genomic data
with cervical and myometrial gene array data derived from
our own group, clearly identifies several genes which are
up-regulated in all three tissue types, with pro-inflamma-BMC Pregnancy and Childbirth 2007, 7(Suppl 1):S7 http://www.biomedcentral.com/1471-2393/7/S1/S7
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tory and chemotactic genes feature prominently, suggest-
ing that labour is associated with a core inflammatory
response in all gestational tissues.
Peripheral blood
Surprisingly little attention has been given to activity and
gene expression of leukocytes in peripheral blood at the
time of parturition. We have recently embarked on studies
to address this issue. Preliminary studies have shown that
chemotaxis of peripheral blood leukocytes and reactive
oxygen species production is greater in blood samples
from labouring compared with non labouring women at
term. If these data are confirmed in larger studies it sug-
gests that leukocytes may be primed and activated in the
peripheral circulation at the onset of labour, with subse-
quent invasion of the myometrium and cervix, thereby
potentially initiating and propagating cervical ripening
and uterine contractions. Therefore circulating leukocytes
are an attractive potential therapeutic target – with inacti-
vation of peripheral leukocytes preventing their initial
influx into myometrium and cervix and their subsequent
cytokine mediated stimulation of uterotonic agents.
Conclusion
Evidence that labour at term is an inflammatory reaction
continues to accumulate. Inflammatory events can be
observed in each of the myometrium, cervix, fetal mem-
branes and peripheral blood. The inflammatory events
which we and others have demonstrated during parturi-
tion at term are paralleled by the effects of infection in
preterm parturition. It is to be hoped that further under-
standing of these events will lead to novel therapeutic
strategies for the treatment and prevention of preterm
labour in due course, and to improved interventions for
cervical ripening and induction of labour.
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